Guruprasad B, Rohan B, Kavitha S, Madhumathi D S, Lokanath D, Appaji L
Department of Medical Oncology, Kidwai Memorial Institute of Oncology, Post graduate hostel Room number 108, Dr M H Marigowda road, Bangalore, 560029 India.
Department of Paediatric Oncology, Kidwai Memorial Institute of Oncology, Bangalore, India.
Indian J Surg Oncol. 2013 Sep;4(3):301-4. doi: 10.1007/s13193-013-0248-5. Epub 2013 Jun 15.
Wilms' tumor is the most common malignant renal tumor in paediatric age group, and is classically managed by multimodal treatment which involves surgery, radiotherapy and chemotherapy. The last few decades have seen a dramatic change in the prognosis of this disease, which once was a uniformly lethal malignancy. While there is plenty of data in world literature on the outcome of Wilms' tumor, there is paucity of data from India. Hence, we conducted the present study to analyze the outcome of Wilms' tumor at our institute. To study the clinicopathologic profile and outcome of Wilms' tumor with NWTS (National Wilms' Tumor Study Group) IV protocol. Sixty-one patients with histopathological proven diagnosis of Wilms' tumor and had received treatment at our institute from Jan 2003 through Dec 2010 were included for analysis. Patients received treatment based on NWTS IV protocol. Patients were analysed for overall survival and event free survival and these outcomes were correlated with age, sex, stage at presentation and histology. Favourable histology which included focal anaplasia was found in 80.3 % while unfavourable histology was elicited in 19.7 % of the cases. The estimated 5 year event-free survival was 83.3 % and overall survival was 85.2 %. Tumour histology was the single most important factor predicting the survival. Patients with childhood Wilms' still present very late in our setting, this poses management challenges as large tumor are technically difficult to deliver at surgery. Histology has a crucial role in outcome of this disease. With multidisciplinary approach, similar survival rates to National Wilms' Tumor Study Group seems to be achievable even in Indian scenario.
肾母细胞瘤是儿童年龄组中最常见的恶性肾肿瘤,传统上采用多模式治疗,包括手术、放疗和化疗。在过去几十年里,这种曾经一致被认为是致命性恶性肿瘤的疾病预后发生了巨大变化。虽然世界文献中有大量关于肾母细胞瘤治疗结果的数据,但来自印度的数据却很少。因此,我们开展了本研究以分析我院肾母细胞瘤的治疗结果。采用美国国家肾母细胞瘤研究组(NWTS)IV方案研究肾母细胞瘤的临床病理特征及治疗结果。纳入2003年1月至2010年12月期间在我院接受治疗、经组织病理学确诊为肾母细胞瘤的61例患者进行分析。患者根据NWTS IV方案接受治疗。分析患者的总生存率和无事件生存率,并将这些结果与年龄、性别、就诊时分期和组织学进行关联。80.3%的病例为预后良好的组织学类型,包括局灶间变,19.7%的病例为预后不良的组织学类型。估计5年无事件生存率为83.3%,总生存率为85.2%。肿瘤组织学是预测生存的唯一最重要因素。在我们的环境中,儿童肾母细胞瘤患者就诊时仍然很晚,这带来了管理挑战,因为大肿瘤在手术中技术上难以切除。组织学在这种疾病的治疗结果中起着关键作用。通过多学科方法,即使在印度的情况下,似乎也能实现与美国国家肾母细胞瘤研究组相似的生存率。